CA2792036A1 - Polymorphe d'acide 2-[3-cyano-4-(2-methylpropoxy) phenyl]-4-methylthiazole-5-carboxylique - Google Patents
Polymorphe d'acide 2-[3-cyano-4-(2-methylpropoxy) phenyl]-4-methylthiazole-5-carboxylique Download PDFInfo
- Publication number
- CA2792036A1 CA2792036A1 CA2792036A CA2792036A CA2792036A1 CA 2792036 A1 CA2792036 A1 CA 2792036A1 CA 2792036 A CA2792036 A CA 2792036A CA 2792036 A CA2792036 A CA 2792036A CA 2792036 A1 CA2792036 A1 CA 2792036A1
- Authority
- CA
- Canada
- Prior art keywords
- febuxostat
- crystalline form
- ketone
- reaction mixture
- process according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Physical Education & Sports Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN488DE2010 | 2010-03-04 | ||
IN488/DEL/2010 | 2010-03-04 | ||
PCT/IB2011/050785 WO2011107911A1 (fr) | 2010-03-04 | 2011-02-24 | Polymorphe d'acide 2-[3-cyano-4-(2-méthylpropoxy) phényl]-4-méthylthiazole-5-carboxylique |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2792036A1 true CA2792036A1 (fr) | 2011-09-09 |
Family
ID=43881251
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2792036A Abandoned CA2792036A1 (fr) | 2010-03-04 | 2011-02-24 | Polymorphe d'acide 2-[3-cyano-4-(2-methylpropoxy) phenyl]-4-methylthiazole-5-carboxylique |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP2542540A1 (fr) |
AU (1) | AU2011222462A1 (fr) |
CA (1) | CA2792036A1 (fr) |
WO (1) | WO2011107911A1 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012038971A2 (fr) | 2010-09-24 | 2012-03-29 | Hetero Research Foundation | Nouveaux polymorphes de febuxostat |
WO2012168948A2 (fr) | 2011-06-06 | 2012-12-13 | Hetero Research Foundation | Procédé de préparation de fébuxostat |
CN104114545B (zh) * | 2011-11-15 | 2018-06-01 | 迈兰实验室有限公司 | 用于制备非布索坦多晶型物的方法 |
CZ27857U1 (cs) | 2014-12-12 | 2015-02-23 | Zentiva, K.S. | Formulace obsahující tuhý roztok febuxostatu |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0513379T3 (da) | 1990-11-30 | 1996-09-30 | Teijin Ltd | 2-Arylthiazolderivater og farmaceutisk præparat indeholdende sådanne |
ATE449765T1 (de) | 1998-06-19 | 2009-12-15 | Teijin Pharma Ltd | Polymorphe modifikationen der 2-(3-cyano-4- isobutylphenyl)-4-methyl-5-thiazol-carbonsäure und verfahren zu ihrer herstellung |
US7541475B2 (en) | 2003-07-30 | 2009-06-02 | Abbott Laboratories | Substituted thiazoles |
CA2656264C (fr) | 2006-06-23 | 2014-07-08 | Teijin Pharma Limited | Methode de production de polymorphes cristallins d'acide 2-(3-cyano-4-(2-methylpropyl)oxyphenyl)-4-methylthiazole-5-carboxylique |
CN101139325B (zh) | 2006-09-07 | 2010-05-12 | 上海医药工业研究院 | 2-(3-氰基-4-异丁氧基苯基)-4-甲基-5-噻唑甲酸晶型及其制备方法 |
CN1970547B (zh) | 2006-12-07 | 2011-04-06 | 重庆医药工业研究院有限责任公司 | 非布司他的晶型及其制备方法 |
CN100546985C (zh) | 2007-06-29 | 2009-10-07 | 上海华拓医药科技发展股份有限公司 | 非布他特微晶及其组合物 |
CN101412700B (zh) | 2007-10-19 | 2011-06-08 | 上海医药工业研究院 | 非布司他的晶型及其制备方法 |
CN101386605B (zh) | 2008-10-23 | 2010-09-08 | 中国科学院上海药物研究所 | 非布司他新型晶体及其制备方法 |
-
2011
- 2011-02-24 WO PCT/IB2011/050785 patent/WO2011107911A1/fr active Application Filing
- 2011-02-24 CA CA2792036A patent/CA2792036A1/fr not_active Abandoned
- 2011-02-24 AU AU2011222462A patent/AU2011222462A1/en not_active Abandoned
- 2011-02-24 EP EP11711672.3A patent/EP2542540A1/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2011107911A1 (fr) | 2011-09-09 |
AU2011222462A1 (en) | 2012-09-27 |
EP2542540A1 (fr) | 2013-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7079527B2 (ja) | 環内チアミジノアミド-アリールアミド系化合物及びb型肝炎を治療するためのその用途 | |
CN109311832B (zh) | 沃替西汀的帕莫酸盐及其晶型 | |
CA2375017C (fr) | Chlorhydrate de compose heterocyclique fusionne | |
WO2010083752A1 (fr) | Febuxostat de haute pureté et son procédé de préparation | |
CN109310674B (zh) | 醛糖还原酶抑制剂及其使用方法 | |
US20110112164A1 (en) | Novel polymorphs and processes for their preparation | |
JP2000072773A (ja) | プリン誘導体 | |
CN103052637B (zh) | 醛糖还原酶抑制剂及其用途 | |
ES2575000T3 (es) | Proceso mejorado para la preparación de ambrisentano | |
JP2008273956A (ja) | レボフロキサシンおよびその形態の調製 | |
EP2536699A2 (fr) | Sels essentiellement purs de fébuxostat et leurs procédés de préparation | |
CA2480352A1 (fr) | Polymorphes de lansoprazole et procedes de preparation de ces derniers | |
CA2792036A1 (fr) | Polymorphe d'acide 2-[3-cyano-4-(2-methylpropoxy) phenyl]-4-methylthiazole-5-carboxylique | |
AU2012241378A1 (en) | Febuxostat solid dispersion | |
CA1244431A (fr) | Derives de phenypiperazine, et leur production | |
US10385017B2 (en) | Pyrrole compound, compositions and process for preparation thereof | |
WO2011080651A2 (fr) | Formes polymorphes de fébuxostat | |
CN1863799B (zh) | 治疗糖尿病和脂质紊乱的色原烷羧酸衍生物 | |
JP2011526615A (ja) | 3−ピロール置換2−インドリノン誘導体の調製 | |
JP2001039976A (ja) | 縮合複素環化合物の塩酸塩 | |
KR101919642B1 (ko) | 피페라진 유도체, 이를 제조하는 방법, 및 인슐린 저항성의 치료에서 이의 용도 | |
AU2009286521A1 (en) | Novel polymorphs of sunitinib and processes for their preparation | |
JP2002220336A (ja) | 縮合複素環化合物の塩酸塩を含有する糖尿病の予防薬、治療薬 | |
CA2566803A1 (fr) | Processus de sechage pour preparer un famciclovir solide cristallin | |
JP2010159293A (ja) | 5−アミノサリチル酸のアゾ誘導体のナトリウム塩 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |
Effective date: 20140225 |